Work

Phase II Clinical Trial: Ex Vivo Drug Sensitivity Testing in Parallel with Physician Selected Selinexor-Based Therapy for Multiple Myeloma

Year: 2024

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2024-208407

Authors: Zachary J. Walker, Deng Wang, Sarah E. Parzych, Lauren T. Reiman, Jacob Joram, Meghan Straubel, Alfonso Roque, Kaylynn Imsande, Katie Zhou, Peter A. Forsberg, Daniel W. Sherbenou

Institution: University of Colorado Anschutz

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4405039953

Cites:

Cited by: 1

Related to: 10